Homocysteine in Renal Transplant Recipients: Association with Transplant Duration and Renal Function

References

• Hannedouche T. P., Kunz K., Muller S., Chantrel F. Homocysteine and chronic renal failure. Advances in Nephrology. Mosby Inc. 1998; Vol. 28: 287–310, Chapter 12
   Google Scholar
• Mudd S. H., Levy H. L. Plasma homocysteine or homocysteine (letter)?. N. Engl. J. Med. 1995; 333: 325, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dennis V. W., Robinson K. Homocystinemia and vascular disease in end stage renal disease. Kidney Int. 1996; 50(Suppl. 57)S11–S17
   Google Scholar
• Arnesen E., Refsum H., Bona K. H., Ueland P. M., Forde O. H., Nordrehaug J. E. Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 1995; 24: 704–709, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Boushey C. J., Beresford S. A.A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049–1057, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chauveau P., Chadefaux B., Coude M., Aupetit J., Hannedouche T., Kamoun P., Jungers P. Hyperhomocystinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int. 1993; 43(Suppl. 41)S72–S77
   Google Scholar
• Robinson K., Gupta A., Dennis V., Arheart K., Chaudhary D., Green R., Vigo P., Mayer E., Selhub J., Kutner M., Jacobsen D. Hyperhomocystinemia confers an independent increased risk of atherosclerosis in end‐stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996; 94: 2743–2748, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bostom A. G., Lathrop L. Hyperhomocystinemia in end stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997; 52: 10–20, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ducloux D., Motte G., Challier B., Gibey R., Chalopin J. M. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J. Am. Soc. Nephrol. 2000; 11: 134–137, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ducloux D., Ruedin C., Gibey R., Vautrin P., Bresson‐Vautrin C., Rebibou J., Chalopin J. Prevalence, determinants, and clinical significance of hyperhomocystinemia in renal‐transplant recipients. Nephrol. Dial. Transplant. 1998; 13: 2890–2893, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Jungers P., Massy Z., Khoa T., Fumeron C., Labrunie M., Lacour B., Descamps‐Latscha B., Man N. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol. Dial. Transplant. 1997; 12: 2597–2602, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Gohh R. Y., Tsai M. Y., Hopkins‐Garcia B. J., Nadeau M. R., Bianchi L. A. Excess prevalence of fasting and post‐methionine loading hyperhomocystinemia in stable renal transplant recipients. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 1894–1900, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dimeny E., Hultberg B., Wahlberg J., Fellstrom B., Arnadottir M. Serum total homocysteine concentration does not predict outcome in renal transplant recipients. Clin. Transplant. 1998; 12: 563–568, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Stein G., Muller A., Busch M., Fleck C., Sperschneider H. Homocysteine, its metabolites, and B‐group vitamins in renal transplant patients. Kidney Int. 2001; 59(Suppl. 78)S262–S265
   Google Scholar
• Arnadottir M., Hultberg B., Wahlberg J., Fellstrom B., Dimeny E. Serum total homocysteine concentration before and after renal transplantation. Kidney Int. 1998; 54: 1380–1384, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lindholm A., Albrectsen D., Frodin L., Tufvesson G., Persson N. H., Lundgren G. Ischemic heart disease—a major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• United States Renal Data System. USRDS. Annual Data Report. The National Institute of Health: National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 1994, , MD
   Google Scholar
• Huh W., Kim B., Kim S. J., Kim Y. G., Kim D. J., Cho J. W., Oh H. Y. Changes of fasting plasma total homocysteine in the early phase of renal transplantation. Transplant. Proc. 2000; 32: 2811–2813, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Fernandez‐Miranda G., Gomez P., Diaz‐Rubio P., Estenoz J., Carrillo J. L., Andres A., Morales J. M. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clin. Transplant. 2000; 14: 110–114, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Krmar R. T., Ferraris J. R., Ramirez J. A., Galarza C. R., Waisman G., Janson J. J., Llapur C. J., Sorroche P., Legal S., Camera M. Hyperhomocystinemia in stable pediatric, adolescents, and young adult renal transplant recipients. Transplantation 2001; 71: 1748–1751, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Arnadottir M., Hultberg B., Vladov V., Nilsson‐Ehle P., Thysell H. Hyperhomocystinemia in cyclosporine‐treated renal transplant recipients. Transplantation 1996; 61: 509–512, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bostom A., Gohh R., Bausserman L., Hakas D., Jacques P., Selhub J., Dworkin L., Rosenberg I. Serum cysteine C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine. J. Am. Soc. Nephrol. 1999; 10: 164–166, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Shaw J., McWhinney B., Tate J., Kesting J., Marczak M., Purdie D., Gibbs H., Cameron D., Hickman P. Plasma homocysteine levels in indigenous Australians. Med. J. Aust. 1999; 170: 19–22, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bunout D., Petermann M., de la Maza P., Kauffmann R., Suazo M., Hirsch S. Serum homocysteine levels in healthy Chilean adults. Rev. Med. Chile 1998; 126: 905–910, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Pastore A., Massoud R., Motti C., Lo‐Russo A., Fucci G., Cortese C., Federici G. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2‐mercaptopropionylglycine in plasma and urine. Clin. Chem. 1998; 44: 825–832, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tonstad S. Correlates of plasma total homocysteine in patients with hyperlipidemia. Eur. J. Clin. Investig. 1997; 27: 1025–1029, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lussier‐Cacan S., Xhignesse M., Piolot A., Selhub J., Davignon J., Genest J., Jr. Plasma total homocysteine in healthy subjects: sex–specific relation with biological traits. Am. J. Clin. Nutr. 1996; 64: 587–593, [CSA]
   PubMed Web of Science ®Google Scholar
• Massy Z. A., Chadefaux V. B., Chavalier A., Bader C. A., Drueke T. B., Legendre C., Lacour B., Kamoun P., Kreis H. Hyperhomocystinemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol. Dial. Transplant. 1994; 9: 1103–1108, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hultberg B., Anderson A., Sterner G. Plasma homocysteine in renal failure. Clin Nephrol. 1993; 40: 230–235, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Janssen M. J., van den Berg M., Stehouwer C. D., Boers G. H. Hyperhomocystinemia: a role in the accelerated atherogenesis of chronic renal failure. Neth. J. Med. 1995; 46: 244–251, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Selhub J., Miller J. W. The pathogenesis of homocystinemia: interruption of the coordinate regulation by s‐adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 1992; 55: 131–138, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bostom A., Gohh R., Beaulieu A., Nadeau M., Hume A., Jacques P., Selhub J., Rosenberg I. Treatment of hyperhomocystinemia in renal transplant recipients. A randomized, placebo‐controlled trial. Ann. Intern. Med. 1997; 127: 1089–1092, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Arnadottir M., Hultberg B. Treatment with high dose folic acid effectively lowers plasma homocysteine concentration in cyclosporin‐treated renal transplant recipients. Transplantation 1997; 64: 1087, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wilken D. E.L., Gupta V. J., Betts A. K. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin. Sci. 1981; 61: 743
   Google Scholar
• Sprung J., Kapural L., Bourke D. L., O'Hara J. F. Anesthesia for kidney transplant surgery. Anesthesiol. Clin. North Am. 2000; 18: 919–951, [CSA]
   Google Scholar